-
Kite Pharma Gains 2% After Management Provides Update To A Phase 1 Study
Wednesday, April 20, 2016 - 8:38am | 366Read More...Shares of Kite Pharma Inc (NASDAQ: KITE) were trading higher by more than 2 percent early Wednesday morning after the company's management provided an update on an ongoing Phase 1 trial at an industry conference. Kite Pharma's management spoke at the American Association of Cancer Research's annual...
-
Kite Pharma Falls 6%, Co. Confirms Review Of All Facilities Involving Sterile Material
Monday, April 18, 2016 - 10:21am | 154Read More...Shares of Kite Pharma Inc (NASDAQ: KITE) were trading lower by more than 6 percent Monday morning after the clinical-stage bio-pharmaceutical company confirmed that its facilities are undergoing a voluntary review. Kite Pharma said its cell therapy manufacturing facilities at the National Cancer...
